NAD+ utilization in Pasteurellaceae: Simplification of a complex pathway

Journal of Bacteriology

Volumn 188, Issue 19, 2006, Pages 6719-6727

  Gerlach, Gabriele ^a   Reidl, Joachim ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BLOOD CLOTTING FACTOR 5; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE NUCLEOSIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NUCLEOSIDE PHOSPHORYLASE; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHATASE; RIBONUCLEOSIDE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BLOOD LEVEL; COMPARATIVE STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; GENE FUNCTION; GENETIC CONSERVATION; GENOME ANALYSIS; HAEMOPHILUS DUCREYI; HAEMOPHILUS INFLUENZAE; HUMAN; NONHUMAN; PASTEURELLACEAE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REDUCTION; REGULATORY MECHANISM; SHORT SURVEY; SUGAR TRANSPORT;

ANIMALS; BACTERIAL PROTEINS; HUMANS; NAD; NIACINAMIDE; PASTEURELLACEAE; REPRESSOR PROTEINS;

PASTEURELLACEAE;

EID: 33749347331     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.00432-06     Document Type: Short Survey

References (91)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Andersen, C., E. Maier, G. Kemmer, J. Blass, A. K. Hilpert, R. Benz, and J. Reidl. 2003. Porin OmpP2 of Haemophilus influenzae shows substrate specificity towards nicotinamide-derived nucleotide substrates. J. Biol. Chem. 278:24269-24276.
3. Barcak, G. J., M. S. Chandler, R. J. Redfield, and J. F. Tomb. 1991. Genetic systems in Haemophilus influenzae. Methods Enzymol. 204:321-342.
4. Becker, D., M. Selbach, C. Rollenhagen, M. Ballmaier, T. F. Meyer, and D. Bumann. 2006. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440:303-307.
5. Berger, F., M. H. Ramirez-Hernandez, and M. Ziegler. 2004. The new life of a centenarian: signaling functions of NAD(P). Trends Biochem. Sci. 29:111-118.
6. + in fungi and humans. Cell 117:495-502.
7. Bong, C. T., M. E. Bauer, and S. M. Spinola. 2002. Haemophilus ducreyi: clinical features, epidemiology, and prospects for disease control. Microbes Infect. 4:1141-1148.
8. Bordenstein, S. R., and W. S. Reznikoff. 2005. Mobile DNA in obligate intracellular bacteria. Nat. Rev. Microbiol. 2005:688-699.
9. Bragg, R. R., L. Coetzee, and J. A. Verschoor. 1993. Plasmid-encoded NAD independence in some South African isolates of Haemophilus paragallinarum. J. Vet. Res. 60:147-152.
10. Busch, W., and M. H. J. Saier. 2002. The transporter classification (TC) system. Crit. Rev. Biochem. Mol. Biol. 37:287-337.
11. Chen, S. J., C. L. Liao, S. L. Hsieh, M. L. Chu, M. C. Fang, H. K. Sytwu, and C. C. Wang. 2006. Kinetics of adaptive immunity to Haemophilus influenzae type b meningitis in transgenic mice: evidence from diverse expression of double T1/T2 transgenes and Th1/Th2-related cytokines. Immunol. Lett. 105:6-15.
12. Coleman, H. N., D. A. Daines, J. Jarisch, and A. L. Smith. 2003. Chemically defined media for growth of Haemophilus influenzae strains. J. Clin. Microbiol. 41:4408-4410.
13. Cooney, D. A., H. N. Jayaram, R. I. Glazer, J. A. Kelley, V. E. Marquez, G. Gebeyehu, A. C. Van Cott, L. A. Zwelling, and D. G. Johns. 1983. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity. Adv. Enzyme Regul. 21:271-303.
14. Cynamon, M. H., T. B. Sorg, and A. Patapow. 1988. Utilization and metabolism of NAD by Haemophilus parainfluenzae. J. Gen. Microbiol. 134:2789-2799.
15. Czuprynski, C. J., F. Leite, M. Sylte, C. Kuckleburg, R. Schultz, T. Inzana, E. Behling-Kelly, and L. Corbeil. 2004. Complexities of the pathogenesis of Mannheimia haemolytica and Haemophilus somnus infections: challenges and potential opportunities for prevention? Anim. Health Res. Rev. 5:277-282.
16. Denicola-Seoane, A., and B. M. Anderson. 1990. Studies of NAD kinase and NMN:ATP adenylyltransferase in Haemophilus influenzae. J. Gen. Microbiol. 136:425-430.
17. Elvehjem, C. A., R. J. Madden, F. M. Strong, and D. W. Woolley. 1938. The isolation and identification of the anti-black tongue factor. J. Biol. Chem. 123:137-149.
18. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, K. McKenney, G. Sutton, W. FitzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L. I. Liu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Frichman, J. L. Fuhrmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
19. Foster, J. W., Y. K. Park, T. Penfound, T. Fenger, and M. P. Specter. 1990. Regulation of NAD metabolism in Salmonella typhimurium: molecular sequence analysis of the bifunctional nadR regulator and the nadA-pnuC operon. J. Bacteriol. 172:4187-4196.
20. Foster, J. W., and T. Penfound. 1993. The bifunctional NadR regulator of Salmonella typhimurium: location of regions involved with DNA binding, nucleotide transport and intramolecular communication. FEMS Microbiol. Lett. 112:179-184.
21. Frick, D. N., and M. J. Bessman. 1995. Cloning, purification, and properties of a novel NADH pyrophosphatase. Evidence for a nucleotide pyrophosphatase catalytic domain in MutT-like enzymes. J. Biol. Chem. 270:1529-1534.
22. Gerdes, S. Y., M. D. Scholle, M. D'Souza, A. Bernal, M. V. Baev, M. Farrell, O. V. Kurnasov, M. D. Daugherty, F. Mseeh, B. M. Polanuyer, J. W. Campbell, S. Anantha, K. Y. Shatalin, S. A. K. Chowdhury, M. Y. Fonstein, and A. L. Osterman. 2002. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 184:4555-4572.
23. + regulates intracellular free calcium concentration in human monocytes. Biochem. J. 382:849-856.
24. Ghislain, M., E. Talla, and J. M. Francois. 2002. Identification and functional analysis of the Saccharomyces cerevisiae nicotinamidase gene, PNC1. Yeast 19:215-224.
25. Gil, R., F. J. Silva, J. Pereto, and A. Moya. 2004. Determination of the core of a minimal bacterial gene set. Microbiol. Mol. Biol. Rev. 68:518-537.
26. Gingrich, W., and F. Schient 1944. Codehydrogenase I and other pyridinium compounds as V-factor for Haemophilus influenzae and H. parainfluenzae. J. Bacteriol. 47:535-550.
27. Glass, J. I., N. Assad-Garcia, N. Alperovich, S. Yooseph, M. R. Lewis, M. Marnf, C. A. Hutchison III, H. O. Smith, and J. C. Venter. 2006. Essential genes of a minimal bacterium. Proc. Natl. Acad. Sci. USA 103:425-430.
28. Godek, C. P., and M. H. Cynamon. 1990. In vitro evaluation of nicotinamide riboside analogs against Haemophilus influenzae. Antimicrob. Agents Chemother. 34:1473-1479.
29. Green, B. A., J. E. Farley, T. Quinn-Dey, R. A. Deich, and G. W. Zlotnick. 1991. The e (P4) outer membrane protein of Haemophilus influenzae: biologic activity of anti-e serum and cloning and sequencing of the structural gene. Infect. Immun. 59:3191-3198.
30. Grose, J. H., U. Bergthorsson, Y. Xu, J. Sterneckert, B. Khodaverdian, and J. R. Roth. 2005. Assimilation of nicotinamide mononucleotide requires periplasmic AphA phosphatase in Salmonella enterica. J. Bacteriol. 187:4521-4530.
31. Guse, A. H. 2005. Second messenger function and the structure-activity relationship of cyclic adenosine diphosphoribose (cADPR). FEBS J. 272:4590-4597.
32. Herbert, M., E. Sauer, G. Smethurst, A. Kraiß, A.-K. Hilpert, and J. Reidl. 2003. Nicotinamide ribosyl uptake mutants in Haemophilus influenzae. Infect. Immun. 71:5398-5401.
33. Herbert, M. A., S. Hayes, M. E. Deadman, C. M. Tang, D. W. Hood, and E. R. Moxon. 2002. Signature tagged mutagenesis of Haemophilus influenzae identifies genes required for in vivo survival. Microb. Pathog. 33:211-223.
34. Herriott, R. M., E. Y. Meyer, M. Vogt, and M. Modan. 1970. Defined medium for growth of Haemophilus influenzae. J. Bacteriol. 101:513-516.
35. Hotomi, M., Y. Ikeda, M. Suzumoto, K. Yamauchi, B. A. Green, G. Zlotnick, D. S. Billal, J. Shimada, K. Fujihara, and N. Yamanaka. 2005. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 23:1294-1300.
36. Kahn, D. W., and B. M. Anderson. 1986. Characterization of Haemophilus influenzae nucleotide pyrophosphatase. J. Biol. Chem. 261:6016-6025.
37. Kemmer, G., T. J. Reilly, J. Schmidt-Brauns, G. W. Zlotnik, B. A. Green, M. J. Fiske, M. Herbert, A. Kraiß, S. Schlör, A. Smith, and J. Reidl. 2001. NadN and e (P4) are essential for utilization of NAD and nicotinamide but not nicotinamide riboside in Haemophilus influenzae. J. Bacteriol. 183:3974-3981.
38. Kielstein, P., H. Wuthe, O. Angen, R. Mutters, and P. Ahrens. 2001. Phenotypic and genetic characterization of NAD-dependent Pasteurellaceae from the respiratory tract of pigs and their possible pathogenetic importance. Vet. Microbiol. 81:243-255.
39. Kilian, M. 1991. Haemophilus, p. 463-470. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
40. Kimura, R., Y. Hayashi, T. Takeuchi, M. Shimizu, M. Iwata, J. Tanahashi, and M. Ito. 2004. Pasteurella multocida septicemia caused by close contact with a domestic cat: case report and literature review. J. Infect. Chemother. 10:250-252.
41. Krehl, W. A., L. J. Trepley, P. S. Sarma, and C. A. Elvehjem. 1945. Growth retarding effect of corn in niacin-rations and its counter-action by tryptophan. Science 101:489-490.
42. Kumasov, O. V., B. M. Polanuyer, S. Ananta, R. Sloutsky, A. Tam, S. Y. Gerdes, and A. L. Osterman. 2002. Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis. J. Bacteriol. 184:6906-6917.
43. Lerner, F., M. Niere, A, Ludwig, and M. Ziegler. 2001. Structural and functional characterization of human NAD kinase. Biochem. Biophys. Res. Commun. 288:69-74.
44. Madden, J. C., N. Ruiz, and M. Caparon. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria. Cell 104:143-152.
45. Magni, G., A. Amid, M. Emanuelli, G. Orsomando, N. Raffaelli, and S. Ruggieri. 2004. Structure and function of nicotinamide mononucleotide adenylyltransferase. Curr. Med. Chem. 11:873-885.
46. Marchler-Bauer, A., J. B. Anderson, C. DeWeese-Scott, N. D. Fedorova, L. Y. Geer, S. He, D. I. Hunvitz, J. D. Jackson, A. R. Jacobs, C. J. Lanczycki, C. A. Liebert, C. Liu, T. Madej, G. H. Marchler, R. Mazumder, A. N. Nikolskaya, A. R. Panchenko, B. S. Rao, B. A. Shoemaker, V. Simonyan, J. S. Song, P. A. Thiessen, S. Vasudevan, Y. Wang, R. A. Yamashita, J. J. Yin, and S. H. Bryant. 2003. CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res. 31:383-387.
47. Martin, P. R., R. J. Shea, and M. H. Mulks. 2001. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J. Bacteriol. 183:1168-1174.
48. + biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae. J. Bacteriol. 187:4410-4420.
49. Micheli, V., and S. Sestini. 1997. Determining NAD synthesis in erythrocytes. Methods Enzymol. 280:211-221.
50. Miller, W. H., M. A. Seefeld, K. A. Newlander, I. N. Uzinskas, W. J. Burgess, D. A. Heerding, C. C. Yuan, M. S. Head, D. J. Payne, S. F. Rittenhouse, T. D. Moore, S. C. Pearson, V. Berry, W. E. J. DeWolf, P. M. Keller, B. J. Polizzi, X. Qiu, C. A. Janson, and W. F. Huffman. 2002. Discovery of aminopyridine-based inhibitors of bacterial enoyl-ACP reductase (FabI). J. Med. Chem. 45:3246-3256.
51. Moran, N. A., and G. R. Plague. 2004. Genomic changes following host restriction in bacteria. Curr. Opin. Genet. Dev. 14:627-633.
52. Moxon, E. R., M. P. Glode, A. Sutton, and J. B. Robbins. 1977. The infant rat as a model of bacterial meningitis. J. Infect. Dis. 136:186-190.
53. Moxon, R. E. 1995. Haemophilus influenzae, p. 2039-2045. In G. L. Mandel, J. E. Bennet, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, N.Y.
54. Munson, R. S., Jr., H. Zhong, R. Mungur, W. C. Ray, R. J. Shea, G. G. Mahairas, and M. H. Mulks. 2004. Haemophilus ducreyi strain ATCC 27722 contains a genetic element with homology to the Vibrio RS1 element that can replicate as a plasmid and confer NAD independence on Haemophilus influenzae. Infect. Immun. 72:1143-1146.
55. Novotny, L. A., K. M. Mason, and L. O. Bakaletz. 2005. Development of a chinchilla model to allow direct, continuous, biophotonic imaging of bioluminescent nontypeable Haemophilus influenzae during experimental otitis media. Infect. Immun. 73:609-611.
56. O'Reilly, T., and D. F. Niven. 1986. Defining the metabolic and growth responses of porcine haemophili to exogenous pyridine nucleotides and precursors. J. Gen. Microbiol. 132:807-818.
57. O'Reilly, T., and D. F. Niven. 2003. Levels of nicotinamide adenine dinucleotide in extracellular body fluids of pigs may be growth-limiting Actinobacillus pleuropneumoniae and Haemophilus parasuis. Can. J. Vet. Res. 67:229-231.
58. O'Reilly, T., D. F. Niven, and M. R. W. Brown. 1991. Phenotypic variation in the outer membrane protein composition of Actinobacillus pleuropneumoniae: non-specific effect of exogenous pyridine nucleotide supply. Vet. Microbiol. 29:159-172.
59. Ou, Z., R. L. Felts, T. J. Reilly, J. C. Nix, and J. J. Tanner. 2006. Crystallization of recombinant Haemophilus influenzae e(P4) acid phosphatase. Acta Crystallogr. F Struct. Biol. Crystalliz. Commun. 62:464-466.
60. Papapanou, P. N. 2002. Population studies of microbial ecology in periodontal health and disease. Ann. Periodontol. 7:54-61.
61. Partida-Sanchez, S., D. A. Cockayne, S. Monard, E. L. Jacobson, N. Oppenheimer, B. Garvy, K. Kusser, S. Goodrich, M. Howard, A. Harmsen, T. D. Randall, and F. E. Lund. 2001. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat. Med. 7:1209-1216.
62. Partida-Sanchez, S., T. D. Randall, and F. E. Lund. 2003. Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity. Microb. Infect. 5:49-58.
63. Paturel, L., J. P. Casalta, G. Habib, M. Nezri, and D. Raoult. 2004. Actinobacillus actinomycetemcomitans endocarditis. Clin. Microbiol. Infect. 10:98-118.
64. Penfound, T., and J. W. Foster. 1996. Biosynthesis and recycling of NAD, p. 721-730. In F. C. Neidhardt et al. (ed.), Escherichia coli and Salmonella; cellular and molecular biology, vol. 1, 2nd ed. ASM Press, Washington, D.C.
65. Penfound, T., and J. W. Foster. 1999. NAD-dependent DNA-binding activity of the bifunctional NadR regulator of Salmonella typhimurium. J. Bacteriol. 181:648-655.
66. Pfister, M., A. Ogilvie, C. P. da Silva, A, Grahnert, A. H. Guse, and S. Hauschildt. 2001. NAD degradation and regulation of CD38 expression by human monocytes/macrophages. Eur. J. Biochem. 268:5601-5608.
67. Preiss, J., and P. Handler. 1958. Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J. Biol. Chem. 233:488-492.
68. Raffaelli, N., T. Lorenzi, P. L. Mariani, M. Emanuelli, A. Amici, S. Ruggieri, and G. Magni. 1999. The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity. J. Bacteriol. 181:5509-5511.
69. Raghunathan, A., N. D. Price, M. Y. Galperin, K. S. Makarova, S. Purvine, A. F. Picone, T. Cherny, T. Xie, T. J. Reilly, R. J. Munson, R. E. Tyler, B. J. Akerley, A. L. Smith, B. O. Palsson, and E. Kolker. 2004. In silico metabolic model and protein expression of Haemophilus influenzae strain Rd KW20 in rich medium. OMICS J. Integr. Biol. 8:25-41.
70. Rawling, J. M., M. M. ApSimon, and J. B. Krikland. 1996. Lung poly(ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat. Free Radic. Biol. Med. 20:865-871.
71. Reidl, J., S. Schlör, A. Kraiss, J. Schmidt-Brauns, G. Kemmer, and E. Soleva. 2000. NADP and NAD utilization in Haemophilus influenzae. Mol. Microbiol. 35:1573-1581.
72. Reilly, T. J., D. L. Chance, and A. L. Smith. 1999. Outer membrane lipoprotein e (P4) of Haemophilus influenzae is a novel phosphomonoesterase. J. Bacteriol. 181:6797-6800.
73. Rongvaux, A., R. J. Shea, M. H. Mulks, D. Gigot, J. Urbain, O. Leo, and F. Andris. 2002. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 32:3225-3234.
74. Saier, M. H. J. 2000. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev. 64:354-411.
75. Sauer, E., M. Merdanovic, A. Price Mortimer, G. Bringmann, and J. Reidl. 2004. PnuC and the utilization of the nicotinamide riboside analog 3-amino-pyridine in Haemophilia influenzae. Antimicrob. Agents Chemother. 48:4532-4541.
76. Saunders, P. P., M. T. Tan, C. D. Spindler, and R. K. Robins. 1989. Phosphorylation of 3-deazaguanosine by nicotinamide riboside kinase in Chinese hamster ovary cells. Cancer Res. 49:6593-6599.
77. Schmidt-Brauns, J., M. Herbert, G. Kemmer, A. Kraiß, S. Schlör, and J. Reidl. 2001. Is a NAD-pyropbosphatase activity needed by Haemophilus influenzae type b for multiplication in the blood stream? Int. J. Med. Microbiol. 291:219-225.
78. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
79. Shifrine, M., and E. L. Biberstein. 1960. A growth factor for Haemophilus species secreted by a pseudomonad. Nature 187:623.
80. Singh, S. K., O. V. Kurnasov, B. Chen, H. Robinson, N. V. Grishin, A. L. Osterman, and H. Zhang. 2002. Crystal structure of Haemophilus influenzae NadR protein: a bifunctional enzyme endowed with NMN adenylyltransferase and ribosylnicotinamide kinase activities. J. Biol. Chem. 277:33291-33299.
81. Spinola, S. M., M. E. Bauer, and R. S. Munson, Jr. 2002. Immunopathogenesis of Haemophilus ducreyi infection (chancroid). Infect. Immun. 70:1667-1676.
82. Van Overbeke, I., K. Chiers, G. Charlier, I. Vandenberghe, J. Van Beeumen, R. Ducatelle, and F. Haesebrouck. 2002. Characterization of the in vitro adhesion of Actinobacillus pleuropneumoniae to swine alveolar epithelial cells. Vet. Microbiol. 88:59-74.
83. Vinitsky, A., and C. Grubmeyer. 1993. A new paradigm for biochemical energy coupling. Salmonella typhimurium nicotinate phosphoribosyltransferase. J. Biol. Chem. 268:26004-26010.
84. Wade, T., R. Booy, E. L. Teare, and S. Kroll. 1999. Pasteurella multocida meningitis in infancy. Eur. J. Pediatr. 158:875-878.
85. Windsor, H. M., R. C. Gromkova, and H. J. Koomhof. 1993. Growth characteristics of V factor-independent transformants of Haemophilus influenzae. Int. J. Syst. Bacteriol. 43:799-804.
86. Windsor, H. M., R. C. Gromkova, and H. J. Koomhof. 1991. Plasmid-mediated NAD independence in Haemophilus parainfluenzae. J. Gen. Microbiol. 137:2415-2421.
87. Zagursky, R. J., P. Ooi, K. F. Jones, M. J. Fiske, R. P. Smith, and B. A. Green. 2000. Identification of a Haemophilus influenzae 5′-nucleotidase protein; cloning of the nucA gene and immunogenicity and characterization of the NucA protein. Infect. Immun. 68:2525-2534.
88. Zhu, N., B. M. Olivera, and J. R. Roth. 1991. Activity of the nicotinamide mononucleotide transporter system is regulated in Salmonella typhimurium. J. Bacteriol. 173:1311-1320.
89. Zhu, N., and J. R. Roth. 1991. The nadI region of Salmonella typhimurium encodes a bifunctional regulatory protein. J. Bacteriol. 173:1302-1310.
90. Zientz, E., T. Dandekar, and R. Gross. 2004. Metabolic interdependence of obligate intracellular bacteria and their insect hosts. Microb. Mol. Biol. Rev. 68:745-770.
91. + transport across cell membranes. FASEB J. 13:273-283.